Cargando…
Phosphodiesterase type 5 inhibitors usage and prostate cancer: a match-paired analysis
BACKGROUND: To treat erectile dysfunction (ED), phosphodiesterase type 5 inhibitors (PDE5i) are commonly used. However, to date, only a few studies exist evaluate a possible effect on the incidence of prostate cancer. One such study completed by the authors’ institution suggested men who use PDE5i f...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673806/ https://www.ncbi.nlm.nih.gov/pubmed/29184786 http://dx.doi.org/10.21037/tau.2017.06.02 |